1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Membrane Technology Market in Pharmaceutical, Biopharma and Life Sciences - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019

Membrane technology is widely used in various development phases of pharmaceutical, biopharmaceutical and life sciences industries. Membrane technology includes membrane applications from laboratory drug research to large scale pharmaceutical manufacturing. Applications of membrane technology in pharmaceutical, life sciences and biopharmaceutical industries include lab-scale DNA and protein separation and analysis, drug screening, cell culturing and examination, and virus removal. Single-use disposable technique for biopharmaceuticals and stringent environmental regulations are some of the key factors driving demand for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries. Strict quality and safety standards in pharmaceutical and biopharmaceutical industries, including Good Manufacturing Practices (GMP), have created a demand for membrane technology in pharmaceutical, biopharma and life sciences industry.

On the other hand, high capital and operational cost impede the growth of the membrane technology market in pharmaceutical, biopharmaceutical and life sciences industries. Membrane fouling is one of the major concerns with membrane technology; it decreases membrane efficiency. Membrane filters need to be replaced or washed every three to four years to remove foulants. However, in the absence of an alternate and more efficient filtration technology, demand for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries is expected to witness healthy growth.

The report provides an in-depth analysis of estimation of the membrane technology market in pharmaceutical, biopharmaceutical and life sciences industries from 2014 to 2019, considering 2013 as the base year for calculation. Additionally, data pertaining to current market dynamics, including market drivers, restraints, trends and recent developments, has been provided in the report. The global membrane technology market in pharmaceutical, biopharmaceutical and life sciences industries is categorized on the bases of type of filtration, processes and geography. The type of processes comprise ultrafiltration, microfiltration, nanofiltration, reverse osmosis and chromatography.

Under geographic analysis, the report identifies and analyses market size and forecast of membrane technology for pharmaceutical, biopharma and life sciences industry in North America, Europe, Asia and Rest of the World (RoW). Some of the major players in the membrane technology market for pharmaceutical, biopharma and life sciences industry are GE Healthcare, Pall Corporation, Sartorius, Merck Millipore and 3M Healthcare. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability and financial overview.

Table Of Contents

Membrane Technology Market in Pharmaceutical, Biopharma and Life Sciences - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019
Table of Content

Chapter 1 Preface 8
1.1 Report Description 8
1.2 Research Methodology 9
1.2.1 Sources 9
1.2.1.1 Secondary Research 9
1.2.1.2 Primary Research 10
1.2.1.3 Assumptions 10

Chapter 2 Executive Summary 11
2.1 Market Snapshot: Global market for membrane technology in pharmaceutical, biopharmaceutical and life science industries (2013 and 2019) 11

Chapter 3 Market Overview 13
3.1 Introduction 13
3.2 Market Drivers and Opportunities 15
3.2.1 Single-use disposable technique for biopharmaceutical 16
3.2.2 Stringent environmental regulations 16
3.2.3 Globally rising pharmaceutical production 17
3.2.4 Business opportunities lie in product innovation/modification 18
3.3 Restraints and Challenges 19
3.3.1 Effects of membrane fouling on membrane technology 19
3.3.2 High capital and operational cost impede market growth 20
3.3.3 Limitations of membrane materials 20

Chapter 4 Market Trends 22
4.1 Product innovation and portfolio expansion 22
4.2 Rising number of mergers, acquisitions and collaborations 23

Chapter 5 Porter's Five Forces and Market Attractiveness Analysis 24
5.1 Bargaining power of suppliers 24
5.2 Bargaining power of buyers 25
5.3 Threat of new entrants 25
5.4 Threat from substitutes 25
5.5 Degree of competition 25
5.6 Market Attractiveness Analysis: Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography 26

Chapter 6 Global Market Size and Forecast 28

Chapter 7 Technology Segment Analysis 33
7.1 Ultrafiltration 33
7.2 Microfiltration 35
7.3 Nanofiltration 37
7.4 Chromatography 39

Chapter 8 Regional Analysis 42
8.1 Scenario in North America 42
8.2 Scenario in Europe 44
8.3 Scenario in Asia 48
8.4 Rest of the World 51

Chapter 9 Competitive Landscape 53

Chapter 10 Company Profiles 58
10.1.1 Overview 58
10.1.2 Products and Segments 58
10.1.3 Financial Performance 59
10.2 Sartorius 60
10.2.1 Overview 60
10.2.2 Products and Segments 60
10.2.3 Financial Performance 61
10.3 3M Company 62
10.3.1 Overview 62
10.3.2 Products and Segments 62
10.3.3 Financial Performance 63
10.4 Merck Millipore 64
10.4.1 Overview 64
10.4.2 Products and Segments 64
10.4.3 Financial Performance 64
10.5 GE Healthcare Life Sciences 66
10.5.1 Overview 66
10.5.2 Products and Segments 66
10.5.3 Financial Performance 67
10.6 Koch Membrane System 68
10.6.1 Overview 68
10.6.2 Products and Segments 68
10.6.3 Financial Performance 69
10.7 Novasep 70
10.7.1 Overview 70
10.7.2 Products and Segments 70
10.7.3 Financial Performance 71
10.8 Trisep Corporation 72
10.8.1 Overview 72
10.8.2 Products and Segments 72
10.8.3 Financial Performance 73
10.9 Amazon Filters 74
10.9.1 Overview 74
10.9.2 Products and Segments 74
10.9.3 Financial Performance 74
10.10 Advantec MFS 75
10.10.1 Overview 75
10.10.2 Products and Segments 75
10.10.3 Financial Performance 76

List of Figures

FIG. 1 Membrane technology usage in pharmaceutical, biopharmaceutical and life sciences industries 14
FIG. 2 Global pharmaceutical market size, 2011 - 2020 (USD million) 18
FIG. 3 Global market for membrane technology in pharmaceutical, biopharmaceutical and life science industries: Porter's five forces analysis 24
FIG. 4 Market attractiveness analysis: Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography 27
FIG. 5 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by segment 2013 and 2019 28
FIG. 6 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by geography in 2013 and 2019 30
FIG. 7 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by technology in 2013 and 2019 31
FIG. 8 Global market for ultrafiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography in 2013 and 2019 33
FIG. 9 Global market for microfiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography in 2013 and 2019 36
FIG. 10 Global market for nanofiltration in pharmaceutical/biopharmaceutical/life science industry size, by geography in 2013 and 2019 38
FIG. 11 Global market for chromatography in pharmaceutical, biopharmaceutical and life sciences industries size, by geography in 2013 and 2019 39
FIG. 12 The North American market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography, in 2013 43
FIG. 13 The European market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography in 2013 46
FIG. 14 The Asian market for membrane technology in pharmaceutical, biopharmaceutical, life science industries, by geography in 2013 49
FIG. 15 Competitive landscape of membrane technology market in pharmaceutical, biopharmaceutical and life sciences industries 53
FIG. 16 Strategic developments in membrane technology market for pharmaceutical, biopharmaceutical and life sciences industries (2011- January 2014) 54

List of Tables

TABLE 1 Market Snapshot: Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries (2014 and 2019) 11
TABLE 2 Major products of membrane technology and their application 14
TABLE 3 Drivers for global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries: Impact analysis 15
TABLE 4 Some of the major products innovation/modifications 19
TABLE 5 Restraints for global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industry: Impact analysis 19
TABLE 6 Some of the major products launched by companies (2012-2013) 22
TABLE 7 Some of the major mergers, acquisitions and collaborations (2012-2013) 23
TABLE 8 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by segment 2009-2013 (USD million) 28
TABLE 9 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industry size, by segment 2014-2019 ($ million) 29
TABLE 10 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2009-2013 (USD million) 30
TABLE 11 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2014-2019 (USD million) 31
TABLE 12 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by technology 2009-2013 (USD million) 31
TABLE 13 Global market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by technology 2014-2019 (USD million) 32
TABLE 14 Global market of ultrafiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2009-2013 (USD million) 33
TABLE 15 Global market of ultrafiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2014-2019 (USD million) 34
TABLE 16 Global market of microfiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2009-2013 (USD million) 36
TABLE 17 Global market of microfiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2014-2019 (USD million) 37
TABLE 18 Global market of nanofiltration in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2009-2013 (USD million) 38
TABLE 19 Global market of nanofiltration in pharmaceutical, biopharmaceutical and life sciences industry size, by geography 2014-2019 ($ million) 39
TABLE 20 Global market of chromatography in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2009-2013 (USD million) 40
TABLE 21 Global market of chromatography in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2014-2019 (USD million) 40
TABLE 22 The North American market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography, 2009-2013 (USD million) 43
TABLE 23 The North American market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography 2014-2019 (USD million) 44
TABLE 24 Pharmaceutical industry research and development expenditure in European countries in 2011 45
TABLE 25 Pharmaceutical market size in European countries in 2011 45
TABLE 26 The European market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography 2009-2013 (USD million) 47
TABLE 27 The European market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2014-2019 (USD million) 48
TABLE 28 The Asian market size of membrane technology in pharmaceutical, biopharmaceutical and life sciences industries size, by geography 2009-2013 (USD million) 50
TABLE 29 The Asian market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries, by geography 2014-2019 (USD million) 51
TABLE 30 Pharmaceutical market size of Latin America, Australia and Africa in 2012 (USD billion) 52
TABLE 31 Recent developments - Major product launches (2011-January 2014) 55
TABLE 32 Recent developments - Geographic expansion (2012-January 2014) 56
TABLE 33 Recent developments - Mergers and acquisitions for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries (2011-January 2014) 57

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.